Neoplasm — Understanding Abnormal Tissue Growths

In medical terms, a neoplasm is an uncontrolled, uncoordinated proliferation of cells that persists even after the cessation of the stimulus that evoked it. Under normal physiological conditions, cellular replication and death are meticulously regulated. When genetic mutations disrupt these regulatory pathways, cells multiply independently of normal physiological signals, accumulating into a distinct mass or circulating abnormally in bodily fluids.

Neoplasms are classified into three major categories: benign, premalignant, and malignant. Benign neoplasms remain localised, do not invade surrounding tissues, and do not spread to distant sites. Premalignant neoplasms contain abnormal cells that have the potential to become invasive if left untreated. Malignant neoplasms, commonly known as cancers, possess the capacity to invade adjacent anatomical structures and metastasise to distant organs via the bloodstream or lymphatic system.

Understanding the nature of a neoplasm is fundamental because it guides every clinical decision. Finding a growth does not automatically mean a person has cancer. Establishing whether a neoplasm is benign or malignant determines whether treatment is needed at all, how urgently intervention must begin, and the scope of that intervention. Accurate identification spares patients with benign tumours from aggressive therapies, whilst ensuring that those with malignant disease receive timely, targeted treatments to control the condition and preserve quality of life.

Diagnosing and characterising a neoplasm begins with imaging, such as ultrasound, CT, MRI, or PET scans, to determine its size and location. The definitive diagnosis requires a tissue biopsy or surgical excision. A pathologist examines the cells under a microscope using histology and immunohistochemistry. Molecular pathology and genomic testing may also be performed on the sample to identify specific genetic mutations or protein markers that influence tumour behaviour.

The term neoplasm applies across all oncology settings. Malignant neoplasms encompass solid tumours such as breast carcinoma, colorectal cancer, lung cancer, and prostate cancer. It also applies to neuroendocrine neoplasms, which arise from hormone-producing cells throughout the digestive tract and lungs. Furthermore, haematological malignancies—such as leukaemia, lymphoma, and multiple myeloma—are liquid neoplasms of the blood-forming tissues and lymphatic network.

Treatment depends entirely on the biological behaviour of the neoplasm. Benign neoplasms may simply be monitored or surgically removed if they press on nerves or vital organs. Malignant neoplasms typically require multimodal care. This may combine surgery to excise the primary growth, radiotherapy to destroy residual cells, and systemic options such as chemotherapy, immunotherapy, or targeted therapy tailored to specific molecular characteristics found within the tumour tissue.